(16.06.2023) Greater diversity in drug supply and use is creating new challenges for drug policy and healthcare in Europe. This is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2023: Trends and Developments in Brussels. The report delivers the latest overview of the drug situation in Europe, exploring key trends and emerging threats.
[ Ссылка ]
